The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes

Previous PostIVIEW Therapeutics Inc. Completes Patient Recruitment for Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe in Dry Eye Disease Patients